GE HealthCare Technologies (GEHC) FCF Margin (2022 - 2026)
GE HealthCare Technologies (GEHC) posted FCF Margin of 2.18% for Q1 2026, down 87.52% on a QoQ basis from 17.5% in Q4 2025, and down 125.0% year-over-year from 8.73% in Q1 2025.
GE HealthCare Technologies (GEHC) FCF Margin (2022 - 2026) Analysis & Trends
GE HealthCare Technologies' FCF Margin history runs 5 years deep, the most recent figure standing at 2.18% for Q1 2026.
- Quarterly FCF Margin fell 125.0% year-over-year to 2.18% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.44% (down 16.0% YoY) and the FY2025 annual result came in at 8.84%, down 37.0% from the prior year.
- FCF Margin was 2.18% for Q1 2026 at GE HealthCare Technologies, down from 17.5% in the prior quarter.
- Across five years, FCF Margin topped out at 23.49% in Q4 2022 and bottomed at 1.74% in Q2 2022.
- A 5-year average of 9.02% and a median of 8.47% in 2022 frame the typical range for FCF Margin.
- Peak annual rise in FCF Margin reached 649 bps in 2024, while the deepest fall reached 728 bps in 2024.
- GE HealthCare Technologies' FCF Margin stood at 23.49% in 2022, then decreased by 2 bps to 23.11% in 2023, then tumbled by 31 bps to 15.83% in 2024, then increased by 11 bps to 17.5% in 2025, then tumbled by 88 bps to 2.18% in 2026.
- Business Quant data shows GEHC's FCF Margin at 2.18% in Q1 2026, 17.5% in Q4 2025, and 11.12% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 15.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.18% |
| Dec 31, 2025 | 17.50% |
| Sep 30, 2025 | 11.12% |
| Jun 30, 2025 | 1.80% |
| Mar 31, 2025 | 3.43% |
| Dec 31, 2024 | 15.83% |
| Sep 30, 2024 | 15.34% |
| Jun 30, 2024 | -1.03% |
| Mar 31, 2024 | 5.89% |
| Dec 31, 2023 | 23.11% |
| Sep 30, 2023 | 8.86% |
| Jun 30, 2023 | 0.12% |
| Mar 31, 2023 | 6.90% |
| Dec 31, 2022 | 23.49% |
| Sep 30, 2022 | 11.98% |
| Jun 30, 2022 | -1.74% |
| Mar 31, 2022 | 8.47% |